These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32151974)

  • 1. CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms.
    Satoh A; Han SI; Araki M; Nakagawa Y; Ohno H; Mizunoe Y; Kumagai K; Murayama Y; Osaki Y; Iwasaki H; Sekiya M; Konishi M; Itoh N; Matsuzaka T; Sone H; Shimano H
    iScience; 2020 Mar; 23(3):100930. PubMed ID: 32151974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice.
    Krumm CS; Xu X; Bare CJ; Holman CD; Kersten S; Dow LE; Lee AH; Cohen DE
    J Biol Chem; 2021 Jul; 297(1):100815. PubMed ID: 34023388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis.
    Park JG; Xu X; Cho S; Hur KY; Lee MS; Kersten S; Lee AH
    Sci Rep; 2016 Jun; 6():27938. PubMed ID: 27301791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha lipoic acid induces hepatic fibroblast growth factor 21 expression via up-regulation of CREBH.
    Bae KH; Min AK; Kim JG; Lee IK; Park KG
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):212-7. PubMed ID: 25449271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Starvation-induced transcription factor CREBH negatively governs body growth by controlling GH signaling.
    Nakagawa Y; Kumagai K; Han SI; Mizunoe Y; Araki M; Mizuno S; Ohno H; Matsuo K; Yamada Y; Kim JD; Miyamoto T; Sekiya M; Konishi M; Itoh N; Matsuzaka T; Takahashi S; Sone H; Shimano H
    FASEB J; 2021 Jun; 35(6):e21663. PubMed ID: 34042217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
    Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
    Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic PTP4A1 ameliorates high-fat diet-induced hepatosteatosis and hyperglycemia by the activation of the CREBH/FGF21 axis.
    Hwang B; Kwon MG; Cho MJ; Lee NK; Lee J; Lee JW; Oh KJ; Bae KH; Hwang JH; Min JK; Park JG
    Theranostics; 2023; 13(3):1076-1090. PubMed ID: 36793871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Fat Content Is Associated with Fasting-Induced Fibroblast Growth Factor 21 Secretion in Mice Fed Soy Proteins.
    Taniguchi H; Akiyama N; Ishihara K
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(6):515-525. PubMed ID: 31902865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MS-275 induces hepatic FGF21 expression via H3K18ac-mediated CREBH signal.
    Zhang Q; Zhu Q; Deng R; Zhou F; Zhang L; Wang S; Zhu K; Wang X; Zhou L; Su Q
    J Mol Endocrinol; 2019 May; 62(4):187-196. PubMed ID: 30893641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects on weight loss and gene expression in adipose and hepatic tissues of very-low carbohydrate and low-fat isoenergetic diets in diet-induced obese mice.
    Yamazaki T; Okawa S; Takahashi M
    Nutr Metab (Lond); 2016; 13():78. PubMed ID: 27826354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine.
    Kim KH; Jeong YT; Oh H; Kim SH; Cho JM; Kim YN; Kim SS; Kim DH; Hur KY; Kim HK; Ko T; Han J; Kim HL; Kim J; Back SH; Komatsu M; Chen H; Chan DC; Konishi M; Itoh N; Choi CS; Lee MS
    Nat Med; 2013 Jan; 19(1):83-92. PubMed ID: 23202295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue.
    Asrih M; Altirriba J; Rohner-Jeanrenaud F; Jornayvaz FR
    PLoS One; 2015; 10(5):e0126364. PubMed ID: 25973847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
    Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
    Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH.
    Bhattacharya A; Sun S; Wang H; Liu M; Long Q; Yin L; Kersten S; Zhang K; Qi L
    EMBO J; 2018 Nov; 37(22):. PubMed ID: 30389665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
    Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
    J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.